Short Description BenevolentAI develops ai drug discovery for aging diseases to support healthy longevity.
Description BenevolentAI is a ai biotech innovator targeting the fundamental mechanisms of aging through ai drug discovery for aging diseases. The company leverages advancements in ai & computational discovery and collaborates with leading institutions to translate cutting‑edge science into practical interventions. By focusing on science‑backed solutions, BenevolentAI aims to extend healthspan and improve quality of life across the globe.
Address 9 rue de Bitbourg, Luxembourg, Luxembourg, UK